UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 180

Sortiert nach

Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide

Clinical cancer research, 2017-11, Vol.23 (22), p.6812-6822

2017

Link zum Volltext

Verfügbarkeit prüfen

Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors

Clinical cancer research, 2015-03, Vol.21 (6), p.1273-1280

2015

Link zum Volltext

Verfügbarkeit prüfen

Association Between Androgen Receptor Splice Variants and Prostate Cancer Resistance to Abiraterone and Enzalutamide

Journal of clinical oncology, 2017-07, Vol.35 (19), p.2103-2105

2017

Link zum Volltext

Verfügbarkeit prüfen

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

Journal of clinical oncology, 2008-03, Vol.26 (7), p.1148-1159

2008

Link zum Volltext

Verfügbarkeit prüfen

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer

Cancer research (Chicago, Ill.), 2006-03, Vol.66 (5), p.2815-2825

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer

Journal of clinical oncology, 2010-03, Vol.28 (9), p.1496-1501

2010

Link zum Volltext

Verfügbarkeit prüfen

Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer

Molecular cancer research, 2015-01, Vol.13 (1), p.98-106

2015

Link zum Volltext

Verfügbarkeit prüfen

Clonal Progression of Prostate Cancers from Gleason Grade 3 to Grade 4

Cancer research (Chicago, Ill.), 2013-02, Vol.73 (3), p.1050-1055

2013

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Enzalutamide Prior to Prostatectomy

Clinical cancer research, 2017-05, Vol.23 (9), p.2169-2176

2017

Link zum Volltext

Verfügbarkeit prüfen

Biology of Prostate-Specific Antigen

Journal of clinical oncology, 2003-01, Vol.21 (2), p.383-391

2003

Link zum Volltext

Verfügbarkeit prüfen

Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer

Journal of clinical oncology, 2012-02, Vol.30 (5), p.507-512

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance

Clinical cancer research, 2021-07, Vol.27 (13), p.3610-3619

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer

Clinical cancer research, 2009-09, Vol.15 (18), p.5794-5802

2009

Link zum Volltext

Verfügbarkeit prüfen

Androgen Receptor Phosphorylation and Stabilization in Prostate Cancer by Cyclin-Dependent Kinase 1

Proceedings of the National Academy of Sciences - PNAS, 2006-10, Vol.103 (43), p.15969-15974

2006

Link zum Volltext

Verfügbarkeit prüfen

Bicalutamide Functions as an Androgen Receptor Antagonist by Assembly of a Transcriptionally Inactive Receptor

The Journal of biological chemistry, 2002-07, Vol.277 (29), p.26321-26326

2002

Link zum Volltext

Verfügbarkeit prüfen

Celecoxib Versus Placebo for Men With Prostate Cancer and a Rising Serum Prostate-Specific Antigen After Radical Prostatectomy and/or Radiation Therapy

Journal of clinical oncology, 2006-06, Vol.24 (18), p.2723-2728

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer

Clinical cancer research, 2009-11, Vol.15 (22), p.7099-7105

2009

Link zum Volltext

Verfügbarkeit prüfen

Imatinib-Induced Regression of AIDS-Related Kaposi's Sarcoma

Journal of clinical oncology, 2005-02, Vol.23 (5), p.982-989

2005

Link zum Volltext

Verfügbarkeit prüfen

Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors

Cancer research (Chicago, Ill.), 2011-10, Vol.71 (20), p.6503-6513

2011

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates

Journal of clinical oncology, 2014-06, Vol.32 (18), p.1889-1894

2014

Link zum Volltext

Verfügbarkeit prüfen

Prostatic Intraepithelial Neoplasia in Mice Expressing an Androgen Receptor Transgene in Prostate Epithelium

Proceedings of the National Academy of Sciences - PNAS, 2001-09, Vol.98 (19), p.10823-10828

2001

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone

Journal of clinical oncology, 2019-04, Vol.37 (11), p.923-931

2019

Link zum Volltext

Verfügbarkeit prüfen

Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies

Cancer, 2021-03, Vol.127 (6), p.840-849

2021

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of Post-Neoadjuvant Intense Hormone Therapy and Surgery for High Risk Localized Prostate Cancer: Results of a Pooled Analysis of Contemporary Clinical Trials

The Journal of urology, 2021-06, Vol.205 (6), p.1689-1697

2021

Link zum Volltext

Verfügbarkeit prüfen

Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer

The New England journal of medicine, 1995-05, Vol.332 (21), p.1393-1398

1995

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 180

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(179)
Mit Volltextzugriff
(165)

Publikationsform

Artikel
(173)
Tagungsberichte
(7)

Sprache

Englisch
(180)
Japanisch
(42)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(30)
Clinical Cancer Research
(16)
Cell Reports
(13)
Cancer Research
(11)
The Journal Of Urology
(11)
Urology
(10)
Cell
(7)
Bju International
(6)
Bioorganic & Medicinal Chemistry Letters
(5)
The New England Journal Of Medicine
(5)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide

Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors

Association Between Androgen Receptor Splice Variants and Prostate Cancer Resistance to Abiraterone and Enzalutamide

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer

Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer

Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer

Clonal Progression of Prostate Cancers from Gleason Grade 3 to Grade 4

Neoadjuvant Enzalutamide Prior to Prostatectomy

Biology of Prostate-Specific Antigen

Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer

Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance

Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer

Androgen Receptor Phosphorylation and Stabilization in Prostate Cancer by Cyclin-Dependent Kinase 1

Bicalutamide Functions as an Androgen Receptor Antagonist by Assembly of a Transcriptionally Inactive Receptor

Celecoxib Versus Placebo for Men With Prostate Cancer and a Rising Serum Prostate-Specific Antigen After Radical Prostatectomy and/or Radiation Therapy

Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer

Imatinib-Induced Regression of AIDS-Related Kaposi's Sarcoma

Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors

Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates

Prostatic Intraepithelial Neoplasia in Mice Expressing an Androgen Receptor Transgene in Prostate Epithelium

Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone

Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies

Outcomes of Post-Neoadjuvant Intense Hormone Therapy and Surgery for High Risk Localized Prostate Cancer: Results of a Pooled Analysis of Contemporary Clinical Trials

Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer

Suchergebnisse filtern